Quality of Life Interventions in Breast Cancer Survivors: State of the Art in Targeted Rehabilitation Strategies.

Breast cancer axillary web syndrome bone loss breast cancer-related lymphedema cancer-related fatigue fatigue lymphedema pain quality of life rehabilitation

Journal

Anti-cancer agents in medicinal chemistry
ISSN: 1875-5992
Titre abrégé: Anticancer Agents Med Chem
Pays: Netherlands
ID NLM: 101265649

Informations de publication

Date de publication:
2022
Historique:
received: 06 11 2020
revised: 06 02 2021
accepted: 15 02 2021
pubmed: 22 6 2021
medline: 29 4 2022
entrez: 21 6 2021
Statut: ppublish

Résumé

Breast cancer is the most common malignant tumor and the most prevalent cause of mortality in women. Advances in early diagnosis and more effective adjuvant therapies have improved the long-term survival of these patients. Pharmacotherapies and intrinsic tumor-related factors may lead to a wide spectrum of treatment-related disabling complications, such as breast cancer-related lymphedema, axillary web syndrome, persistent pain, bone loss, arthralgia, and fatigue. These conditions have a detrimental impact on the health-related quality of life of survivors. Here, we sought to provide a portrait of the role that rehabilitation plays in breast cancer survivors. Particular emphasis has been put in terms of recovering function, improving independence in activities of daily living, and reducing disability. This complex scenario requires a precision medicine approach to provide more effective decision-making and adequate treatment compliance.

Identifiants

pubmed: 34151769
pii: ACAMC-EPUB-116064
doi: 10.2174/1871520621666210609095602
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

801-810

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Marco Invernizzi (M)

Physical and Rehabilitative Medicine, Department of Health Sciences, University of Eastern Piedmont, Novara, Italy.
Translational Medicine, Dipartimento Attività Integrate Ricerca e Innovazione (DAIRI), Azienda Ospedaliera SS, Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.

Alessandro de Sire (A)

Department of Medical and Surgical Sciences, University of Catanzaro \'Magna Graecia\' Catanzaro, Italy.

Konstantinos Venetis (K)

Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Emanuele Cigna (E)

Plastic Surgery Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

Stefano Carda (S)

Neuropsychology and Neurorehabilitation Service, Department of Clinical Neuroscience, Lausanne University Hospital, Lausanne, Switzerland.

Margherita Borg (M)

Physical and Rehabilitative Medicine, Department of Health Sciences, University of Eastern Piedmont, Novara, Italy.

Carlo Cisari (C)

Translational Medicine, Dipartimento Attività Integrate Ricerca e Innovazione (DAIRI), Azienda Ospedaliera SS, Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.

Nicola Fusco (N)

Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH